AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sienna Cancer Diagnostics

0.070

0.000

Volume:- -

Turnover:52.41K

Market Cap:27.66M

PE:-6.20

High:0.070

Open:0.070

Low:0.070

Close:0.070

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Sienna Cancer Diagnostics

Exchange:

ASX

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.siennadiagnostics.com.au

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Sienna Cancer Diagnostics Limited, a medical technology company, identifies, develops, and commercializes cancer-related in-vitro diagnostic tests for use in pathology laboratories worldwide. The company offers SCD-A7, an anti-human telomerase reverse transcriptase antibody for the detection of the biomarker for cancer. It also provides SIEN-NET technology, a sample preparation platform to enhance the performance of liquid biopsy diagnostic assays. The company has a research collaboration agreement with Minomic International Ltd to develop a proprietary test for the early detection of pancreatic cancer. The company was formerly known as Sienna Capital Ltd and changed its name to Sienna Cancer Diagnostics Limited in 2006. Sienna Cancer Diagnostics Limited was founded in 2002 and is headquartered in Scoresby, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SDX.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SDX.AU\",,,,,undefined,":{"symbol":"SDX.AU","market":"AU","secType":"STK","nameCN":"Sienna Cancer Diagnostics","latestPrice":0.07,"timestamp":1749794400000,"preClose":0.07,"halted":3,"volume":0,"delay":0,"nameEN":"Sienna Cancer Diagnostics","floatShares":240871358,"shares":395132839,"eps":-0.011292,"marketStatus":"Halted","change":0,"latestTime":"06-13 16:00:00 AEST","open":0.07,"high":0.07,"low":0.07,"amount":52409.88411331,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.011292,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1750032000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.07,"openAndCloseTimeList":[[1749772800000,1749794400000]],"volumeRatio":0.8866317170209546,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SDX.AU\",,,,,undefined,":{"symbol":"SDX.AU","floatShares":240871358,"roa":"-20.32%","roe":"-35.97%","lyrEps":-0.010558,"volumeRatio":0.8866317170209546,"shares":395132839,"dividePrice":0,"high":0.07,"amplitude":0,"preClose":0.07,"low":0.07,"week52Low":0.07,"pbRate":"3.06","week52High":0.07,"institutionHeld":0,"latestPrice":0.07,"eps":-0.011292,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.011292,"open":0.07,"prevYearClose":0.07,"prevWeekClose":0.07,"prevMonthClose":0.07,"prevQuarterClose":0.07,"fiveDayClose":0.07,"twentyDayClose":0.07,"sixtyDayClose":0.07},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.siennadiagnostics.com.au","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0085},{"period":"1month","weight":0.0534},{"period":"3month","weight":0.0628},{"period":"6month","weight":0.1481},{"period":"1year","weight":0.2169},{"period":"ytd","weight":0.1564}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Sienna Cancer Diagnostics Limited, a medical technology company, identifies, develops, and commercializes cancer-related in-vitro diagnostic tests for use in pathology laboratories worldwide. The company offers SCD-A7, an anti-human telomerase reverse transcriptase antibody for the detection of the biomarker for cancer. It also provides SIEN-NET technology, a sample preparation platform to enhance the performance of liquid biopsy diagnostic assays. The company has a research collaboration agreement with Minomic International Ltd to develop a proprietary test for the early detection of pancreatic cancer. The company was formerly known as Sienna Capital Ltd and changed its name to Sienna Cancer Diagnostics Limited in 2006. Sienna Cancer Diagnostics Limited was founded in 2002 and is headquartered in Scoresby, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.052228},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.121256},{"month":3,"riseRate":0.333333,"avgChangeRate":0.456364},{"month":4,"riseRate":0.666667,"avgChangeRate":0.077652},{"month":5,"riseRate":0,"avgChangeRate":-0.110958},{"month":6,"riseRate":0.666667,"avgChangeRate":0.069854},{"month":7,"riseRate":0.5,"avgChangeRate":-0.164014},{"month":8,"riseRate":1,"avgChangeRate":0.061578},{"month":9,"riseRate":0,"avgChangeRate":-0.088656},{"month":10,"riseRate":0,"avgChangeRate":-0.064815},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.019885},{"month":12,"riseRate":0.666667,"avgChangeRate":0.03017}],"exchange":"ASX","name":"Sienna Cancer Diagnostics","nameEN":"Sienna Cancer Diagnostics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SDX.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SDX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SDX.AU\",market:\"AU\",,,undefined,":[]}}